# About CJC-1295 Ipamorelin Compound: An Editorial Digest

> About CJC-1295 Ipamorelin Compound: an independent editorial project summarizing the peer-reviewed research on the CJC-1295 + ipamorelin stack. Not a clinic. No products.

An editorial console for the literature. Not a clinic, not a vendor.

## What this site is

CJC-1295 Ipamorelin Compound is an independent editorial project that publishes summaries of the peer-reviewed research literature on the CJC-1295 + ipamorelin combination. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The "compound" in the name is editorial framing — a position this publisher occupies relative to the literature on a research *compound*, not a claim to be a compounding pharmacy or to offer any product or service. There is no checkout here and nothing to buy.

## How we read the evidence

The method is plain: state the number, mark the source, leave the gaps visible. Where a finding was measured — CJC-1295's GH and IGF-1 elevations, ipamorelin's selectivity, the GHRP+GHRH synergy — we report it with a citation. Where the combination is inferred from single-component data and general synergy work using related peptides, we say so rather than implying the fixed blend was clinically proven.

We keep the two honesty constraints front and center on every page: neither component is FDA-approved, and the fixed CJC-1295 + ipamorelin combination has never been tested in a controlled clinical trial. The downstream effects people report are logged as anecdote, separated from the cited literature. No human dosing appears anywhere.

## What we don't do

We don't sell peptides, recommend doses, or offer consultations. We don't name drug brands or compare against branded GH products. We don't invent people, addresses, or a clinical team — there are none. We don't claim the stack treats, cures, or prevents anything.

What we do is narrow and deliberate: read the published record on this research combination, render it in plain English alongside the technical detail, and cite all of it. The compounds described are research chemicals; this is a reading room for what the science says about them.

---

Two receptors logged on one onyx panel — the supra-additive GH crest read off single-peptide data and the general synergy work, the fixed blend's missing trial left as an empty cell; no clinic behind the console and nothing here dosed, stacked, or sold.